Roche Stock Rises on AI-Driven Lab Plans
Roche Holding (RHHBY) announced plans for autonomous, AI-driven research laboratories. The company's U.S.-dollar share quote was $52.22 on October 1, 2026, which is 26.62% above the GF Value estimate.
Roche Holding (RHHBY), the global pharmaceuticals and diagnostics company, outlined plans for autonomous, AI-driven research laboratories, while its U.S.-dollar share quote stood at $52.22 on October 1, 2026. That puts the price 26.62% above the $41.24 GF Value estimate. The valuation gap suggests…